Pathstone Family Office »

Regeneron Pharmaceuticals shares owned by Pathstone Family Office

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Pathstone Family Office from 13F filings

Historical chart of Pathstone Family Office investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Pathstone Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Pathstone Family Office

Quarter filed Position value Share count Share price at filing
2012-12-31 $8.0k 47 170.21
2012-09-30 $7.0k 47 148.94

More positions owned by Pathstone Family Office

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
Coca-Cola Company (KO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Whitehall Fds High Div Yld (VYM)

View all positions for Pathstone Family Office

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals